Clinical Trials Directory

Trials / Completed

CompletedNCT06875050

Antioxidant Supplements in Cystic Fibrosis Children

Effect of Antioxidant Supplements on Oxidative Stress, Disease Severity and Bacterial Infection in Cystic Fibrosis Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
6 Months – 18 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled clinical trial included 60 pediatric patients with cystic fibrosis (CF) assigned randomly into two arms; Arm 1(extra care arm):received a tailored dietary plan following Mediterranean diet to cover macronutrients needs according to recommended daily allowance (RDA) for age, with antioxidant supplements in specific doses in oral liquid form (200 mg vitamin E, 300 mg vitamin C, 90 μg Se, 500 μg vitamin A, 30 mg zinc, 3 mg copper and 2000 IU vitamin D) for 6 months. Arm 2: recieved tailored dietary plan following Mediterranean diet as Arm 1 with fat soluble vitamins supplementation (150 μg vitamin A, 2000 IU vitamin D, 100 mg vitamin E and 1000 μg vitamin K) for 6 months. This study aimed to evaluate the effect of antioxidants supplementation on the level of oxidative stress, as measured by 3-Nitrotyrosine, bacterial colonization and diseases severity among CF children.

Conditions

Interventions

TypeNameDescription
OTHERMediterranean dietTailored dietary plan following Mediterranean diet to cover macronutrients needs according to recommended daily allowance (RDA) for age
DIETARY_SUPPLEMENTFat soluble vitamins supplementationFat soluble vitamins supplementation (150 μg vitamin A, 2000 IU vitamin D, 100 mg vitamin E and 1000 μg vitamin K).
DIETARY_SUPPLEMENTAntioxidant SupplementAntioxidant supplements in specific doses in oral liquid form (200 mg vitamin E, 300 mg vitamin C, 90 μg Se, 500 μg vitamin A, 30 mg zinc, 3 mg copper and 2000 IU vitamin D).

Timeline

Start date
2024-03-12
Primary completion
2025-02-13
Completion
2025-03-01
First posted
2025-03-13
Last updated
2025-03-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06875050. Inclusion in this directory is not an endorsement.